For more than twenty years, Liryc’s doctors and researchers have been working on understanding the mechanisms of arrhythmias and the causes of cardiac mortality. Their effort has taken on a whole new dimension with the creation of HIU LYRIC in 2012.
They are studying:
- atrial fibrillation, the most common of rhythm disorders and the main risk factor for strokes;
- ventricular fibrillation, the heart rhythm disorder behind sudden death;
- the desynchronization behind heart failure.
Liryc's researchers and doctors are behind major scientific breakthroughs in the fields of atrial and ventricular fibrillation and cardiac resynchronization therapy which have resulted in new therapeutic strategies implemented worldwide.
Liryc’s uniqueness lies in bringing very diverse and complementary multidisciplinary scientific expertise together with world-class clinical teams in one place, with the ultimate objective of providing better care. The Liryc teams are nowadays making their mark on the international scientific stage by publishing many articles and research projects and also by being leading contributors at major international conferences.
Each team of researchers is at the boundary of clinical research to improve therapeutic solutions.